Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
Launched by UNIVERSITY OF WASHINGTON · Aug 24, 2022
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether nutritional supplements made from milk, specifically lactoferrin and lysozyme, can help children who have had diarrhea and are also malnourished. The goal is to see if these supplements can prevent further episodes of diarrhea and improve the children's nutrition over the next six months. The study is taking place in seven hospitals in Western Kenya and aims to enroll 600 children aged 6 to 24 months who were hospitalized for diarrhea and are ready to go home.
If your child is eligible and you decide to participate, you will need to provide some health information and allow for collection of stool, blood, and possibly urine samples. You will receive sachets of the supplements to mix with your child’s food daily. Over the next six months, you will visit the clinic four times, and a community health worker will come to check on your child every two weeks. The risks of participating are minimal, and the findings from this study could lead to better treatments for children suffering from diarrhea in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 6-24 months
- • Managed as an outpatient or inpatient for diarrhea at one of the recruiting sites
- • MUAC \<12.5 cm at the time of screening
- • Plan to stay within the study area for the next 6 months or greater
- Exclusion Criteria:
- • Age younger than 6 months or older than 24 months
- • Caregiver does not provide consent to study participation
- • History of 2 or more blood transfusions in the past 12 months
- • Exclusively breastfeeding at the time of enrollment
- • History of congenital defect or syndrome that prevents age-appropriate feeding (e.g. cleft palate)
- • History of allergy to dairy products
- • Child is not ready to return home (is not yet discharged), or discharged against medical advice
- • Unwilling to participate in the dual sugar permeability sub-study if selected
- • Enrollment in another study
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homa Bay, , Kenya
Rongo, , Kenya
Isibania, , Kenya
Kisii, , Kenya
Patients applied
Trial Officials
Patricia B Pavlinac
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials